# Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy

> **NCT02966236** · PHASE4 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 192 (estimated)

## Conditions studied

- Nephrolithiasis
- Staghorn Calculus

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02966236
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2018-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02966236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02966236, "Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02966236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*